No evidence of increased risk for Coronavirus Disease 2019 (COVID‐19) in patients treated with Dupilumab for atopic dermatitis in a high‐epidemic area – Bergamo, Lombardy, ItalyAndrea Carugno, Paolo Sena, Donatella Gambini et al.|Journal of the European Academy of Dermatology and Venereology|2020Cited by 48